Miebo (perfluorohexyloctane ophthalmic solution) — Cigna

Initial criteria

• Patient has a diagnosis of dry eye disease (examples include dry eye syndrome and keratoconjunctivitis sicca)
• Patient age ≥ 18 years

Approval duration

1 year